BCLS I Investco, LP 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-08 4:49 pm Unchanged |
2022-08-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 2,721,436 4.500% |
0 (Unchanged) |
Filing |
| 2022-05-27 4:19 pm Sale |
2022-05-25 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 2,721,436 5.300% |
-888,360 (-24.61%) |
Filing |
| 2021-02-08 5:00 pm Unchanged |
2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
BCLS I Investco, LP | 3,609,796 7.400% |
0 (Unchanged) |
Filing |